Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Renato D Lopes

Showing results (11-20 of 730) with videos related to

Pageof 73
Sort By:
Evidence-Based Medicine|August 2, 2011
In people with atrial fibrillation unsuitable for warfarin, apixaban reduces the risk of stroke compared with aspirin, with no difference in major bleedingRenato D Lopes, David A Garcia
European Heart Journal|October 23, 2014
Atrial fibrillation, valvular heart disease, and use of target-specific oral anticoagulants for stroke preventionStefan H Hohnloser, Renato D Lopes
Cardiology|November 13, 2009
Interpreting the TRITON results in light of the event adjudication processRenato D Lopes, Christopher B Granger
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|December 4, 2025
Do we still need more data to adopt a short duration of DAPT routinely following PCI in high bleeding risk patients?Guillaume Marquis-Gravel, Renato D Lopes
European Heart Journal|November 30, 2017
Oral anticoagulation: a step toward solving the puzzle of dementia related to atrial fibrillation?Luciano A Sposato, Renato D Lopes
European Heart Journal|October 25, 2020
Antithrombotic therapy for patients with atrial fibrillation undergoing percutaneous coronary intervention: balance best with double antithrombotic therapyAlexander C Fanaroff, Renato D Lopes
The Journal of Thoracic and Cardiovascular Surgery|July 15, 2019
New antihyperglycemic medications with cardiovascular protection for patients with diabetes: What do surgeons need to know?Neha J Pagidipati, Renato D Lopes
The New England Journal of Medicine|April 17, 2024
Stroke Prevention in Subclinical Atrial Fibrillation. ReplyJeff S Healey, Renato D Lopes
Journal of the American College of Cardiology|October 16, 2020
Anticoagulation in COVID-19: It Is Time for High-Quality EvidenceRenato D Lopes, Alexander C Fanaroff
European Journal of Internal Medicine|September 27, 2023
Standing up for equitable treatment of coronary microvascular dysfunction and myocardial infarction with non-obstructive coronary arteriesAlexander C Fanaroff, Renato D Lopes
Pageof 73

Showing results (11-20 of 730) with videos related to

Sort By:
Pageof 73
Evidence-Based Medicine|August 2, 2011
In people with atrial fibrillation unsuitable for warfarin, apixaban reduces the risk of stroke compared with aspirin, with no difference in major bleedingRenato D Lopes, David A Garcia
European Heart Journal|October 23, 2014
Atrial fibrillation, valvular heart disease, and use of target-specific oral anticoagulants for stroke preventionStefan H Hohnloser, Renato D Lopes
Cardiology|November 13, 2009
Interpreting the TRITON results in light of the event adjudication processRenato D Lopes, Christopher B Granger
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|December 4, 2025
Do we still need more data to adopt a short duration of DAPT routinely following PCI in high bleeding risk patients?Guillaume Marquis-Gravel, Renato D Lopes
European Heart Journal|November 30, 2017
Oral anticoagulation: a step toward solving the puzzle of dementia related to atrial fibrillation?Luciano A Sposato, Renato D Lopes
European Heart Journal|October 25, 2020
Antithrombotic therapy for patients with atrial fibrillation undergoing percutaneous coronary intervention: balance best with double antithrombotic therapyAlexander C Fanaroff, Renato D Lopes
The Journal of Thoracic and Cardiovascular Surgery|July 15, 2019
New antihyperglycemic medications with cardiovascular protection for patients with diabetes: What do surgeons need to know?Neha J Pagidipati, Renato D Lopes
The New England Journal of Medicine|April 17, 2024
Stroke Prevention in Subclinical Atrial Fibrillation. ReplyJeff S Healey, Renato D Lopes
Journal of the American College of Cardiology|October 16, 2020
Anticoagulation in COVID-19: It Is Time for High-Quality EvidenceRenato D Lopes, Alexander C Fanaroff
European Journal of Internal Medicine|September 27, 2023
Standing up for equitable treatment of coronary microvascular dysfunction and myocardial infarction with non-obstructive coronary arteriesAlexander C Fanaroff, Renato D Lopes
Pageof 73